| __timestamp | Geron Corporation | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8901000 | 3243000 |
| Thursday, January 1, 2015 | 9574000 | 2472000 |
| Friday, January 1, 2016 | 14695000 | 2548000 |
| Sunday, January 1, 2017 | 8437000 | 19623000 |
| Monday, January 1, 2018 | 12723000 | 30421000 |
| Tuesday, January 1, 2019 | 51272000 | 32793999 |
| Wednesday, January 1, 2020 | 50052000 | 28304000 |
| Friday, January 1, 2021 | 783000 | 620000 |
| Saturday, January 1, 2022 | 868000 | 755000 |
| Sunday, January 1, 2023 | 123740000 | 1322000 |
Data in motion
In the competitive landscape of biotechnology, cost efficiency is a critical factor for success. This analysis delves into the cost of revenue trends for Geron Corporation and Viridian Therapeutics, Inc. from 2014 to 2023. Over this period, Geron Corporation's cost of revenue fluctuated significantly, peaking in 2023 with a staggering 1,237% increase from its 2021 low. In contrast, Viridian Therapeutics experienced a more stable trajectory, with a notable spike in 2018, reaching its highest cost of revenue.
Understanding these trends provides valuable insights into each company's operational strategies and market positioning, offering investors a clearer picture of their financial health.
Cost of Revenue: Key Insights for GSK plc and Viridian Therapeutics, Inc.
Neurocrine Biosciences, Inc. vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Incyte Corporation vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Dr. Reddy's Laboratories Limited vs Geron Corporation: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Sarepta Therapeutics, Inc. and Geron Corporation
Analyzing Cost of Revenue: Sarepta Therapeutics, Inc. and Viridian Therapeutics, Inc.
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Geron Corporation
Cost Insights: Breaking Down Veracyte, Inc. and Viridian Therapeutics, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: HUTCHMED (China) Limited vs Viridian Therapeutics, Inc.
Cost of Revenue Comparison: Ligand Pharmaceuticals Incorporated vs Geron Corporation
Cost of Revenue Trends: Agios Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
Geron Corporation vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored